TrialInternational wound journal2023

Use of polysaccharide hemostatic agent (HaemoCer™) in breast cancer surgery to reduce postoperative complications: A randomised controlled trial.

Veronica Falcone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.